232 related articles for article (PubMed ID: 33405291)
1. Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial.
Ducrocq G; Calvo G; González-Juanatey JR; Durand-Zaleski I; Avendano-Sola C; Puymirat E; Lemesle G; Arnaiz JA; Martínez-Sellés M; Rousseau A; Cachanado M; Vicaut E; Silvain J; Karam C; Danchin N; Simon T; Steg PG;
Clin Cardiol; 2021 Feb; 44(2):143-150. PubMed ID: 33405291
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
Ducrocq G; Gonzalez-Juanatey JR; Puymirat E; Lemesle G; Cachanado M; Durand-Zaleski I; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Ferrari E; Calvo G; Danchin N; Avendaño-Solá C; Frenkiel J; Rousseau A; Vicaut E; Simon T; Steg PG;
JAMA; 2021 Feb; 325(6):552-560. PubMed ID: 33560322
[TBL] [Abstract][Full Text] [Related]
3. A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).
Reeves BC; Pike K; Rogers CA; Brierley RC; Stokes EA; Wordsworth S; Nash RL; Miles A; Mumford AD; Cohen A; Angelini GD; Murphy GJ
Health Technol Assess; 2016 Aug; 20(60):1-260. PubMed ID: 27527344
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses.
Durand-Zaleski I; Ducrocq G; Mimouni M; Frenkiel J; Avendano-Solá C; Gonzalez-Juanatey JR; Ferrari E; Lemesle G; Puymirat E; Berard L; Cachanado M; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Calvo G; Danchin N; Paco S; Drouet E; Abergel H; Rousseau A; Simon T; Steg PG
Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):194-202. PubMed ID: 35612990
[TBL] [Abstract][Full Text] [Related]
5. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
Carson JL; Brooks MM; Hébert PC; Goodman SG; Bertolet M; Glynn SA; Chaitman BR; Simon T; Lopes RD; Goldsweig AM; DeFilippis AP; Abbott JD; Potter BJ; Carrier FM; Rao SV; Cooper HA; Ghafghazi S; Fergusson DA; Kostis WJ; Noveck H; Kim S; Tessalee M; Ducrocq G; de Barros E Silva PGM; Triulzi DJ; Alsweiler C; Menegus MA; Neary JD; Uhl L; Strom JB; Fordyce CB; Ferrari E; Silvain J; Wood FO; Daneault B; Polonsky TS; Senaratne M; Puymirat E; Bouleti C; Lattuca B; White HD; Kelsey SF; Steg PG; Alexander JH;
N Engl J Med; 2023 Dec; 389(26):2446-2456. PubMed ID: 37952133
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
Carson JL; Brooks MM; Chaitman BR; Alexander JH; Goodman SG; Bertolet M; Abbott JD; Cooper HA; Rao SV; Triulzi DJ; Fergusson DA; Kostis WJ; Noveck H; Simon T; Steg PG; DeFilippis AP; Goldsweig AM; Lopes RD; White H; Alsweiler C; Morton E; Hébert PC;
Am Heart J; 2023 Mar; 257():120-129. PubMed ID: 36417955
[TBL] [Abstract][Full Text] [Related]
7. In patients with AMI and anemia, a restrictive vs. liberal blood transfusion strategy was noninferior for 30-d MACE.
Jiang D; Garcia D
Ann Intern Med; 2021 Jul; 174(7):JC77. PubMed ID: 34224267
[TBL] [Abstract][Full Text] [Related]
8. Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
Mazer CD; Whitlock RP; Fergusson DA; Hall J; Belley-Cote E; Connolly K; Khanykin B; Gregory AJ; de Médicis É; McGuinness S; Royse A; Carrier FM; Young PJ; Villar JC; Grocott HP; Seeberger MD; Fremes S; Lellouche F; Syed S; Byrne K; Bagshaw SM; Hwang NC; Mehta C; Painter TW; Royse C; Verma S; Hare GMT; Cohen A; Thorpe KE; Jüni P; Shehata N;
N Engl J Med; 2017 Nov; 377(22):2133-2144. PubMed ID: 29130845
[TBL] [Abstract][Full Text] [Related]
9. Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
Mazer CD; Whitlock RP; Fergusson DA; Belley-Cote E; Connolly K; Khanykin B; Gregory AJ; de Médicis É; Carrier FM; McGuinness S; Young PJ; Byrne K; Villar JC; Royse A; Grocott HP; Seeberger MD; Mehta C; Lellouche F; Hare GMT; Painter TW; Fremes S; Syed S; Bagshaw SM; Hwang NC; Royse C; Hall J; Dai D; Mistry N; Thorpe K; Verma S; Jüni P; Shehata N;
N Engl J Med; 2018 Sep; 379(13):1224-1233. PubMed ID: 30146969
[TBL] [Abstract][Full Text] [Related]
10. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial.
Meybohm P; Lindau S; Treskatsch S; Francis R; Spies C; Velten M; Wittmann M; Gueresir E; Stoppe C; Kowark A; Coburn M; Selleng S; Baschin M; Jenichen G; Meersch M; Ermert T; Zarbock A; Kranke P; Kredel M; Helf A; Laufenberg-Feldmann R; Ferner M; Wittenmeier E; Gürtler KH; Kienbaum P; de Abreu MG; Sander M; Bauer M; Seyfried T; Gruenewald M; Choorapoikayil S; Mueller MM; Seifried E; Brosteanu O; Bogatsch H; Hasenclever D; Zacharowski K;
Trials; 2019 Feb; 20(1):101. PubMed ID: 30717805
[TBL] [Abstract][Full Text] [Related]
11. Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis.
Ducrocq G; Cachanado M; Simon T; Puymirat E; Lemesle G; Lattuca B; Ariza-Solé A; Silvain J; Ferrari E; Gonzalez-Juanatey JR; Martínez-Sellés M; Lermusier T; Coste P; Vanzetto G; Cottin Y; Dillinger JG; Calvo G; Steg PG;
Can J Cardiol; 2024 Feb; ():. PubMed ID: 38408702
[TBL] [Abstract][Full Text] [Related]
12. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.
Hajjar LA; Vincent JL; Galas FR; Nakamura RE; Silva CM; Santos MH; Fukushima J; Kalil Filho R; Sierra DB; Lopes NH; Mauad T; Roquim AC; Sundin MR; Leão WC; Almeida JP; Pomerantzeff PM; Dallan LO; Jatene FB; Stolf NA; Auler JO
JAMA; 2010 Oct; 304(14):1559-67. PubMed ID: 20940381
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of restrictive versus liberal blood transfusion strategies in acute myocardial infarction and anemia: a systematic review and meta-analysis of randomized controlled trials.
Amin AM; Ali K; Elbenawi H; Saber A; Abuelazm M; Abdelazeem B
Coron Artery Dis; 2024 May; 35(3):239-251. PubMed ID: 38411260
[TBL] [Abstract][Full Text] [Related]
14. Restrictive vs. Liberal Red Blood Cell Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: A Systematic Review and Meta-Analysis.
Zhang Y; Xu Z; Huang Y; Ye Q; Xie N; Zeng L; Lian X; Dai Y; Chen J; He P; Tan N; Liu Y
Front Cardiovasc Med; 2021; 8():736163. PubMed ID: 34869640
[No Abstract] [Full Text] [Related]
15. Transfusion strategies for patients in pediatric intensive care units.
Lacroix J; Hébert PC; Hutchison JS; Hume HA; Tucci M; Ducruet T; Gauvin F; Collet JP; Toledano BJ; Robillard P; Joffe A; Biarent D; Meert K; Peters MJ; ; ;
N Engl J Med; 2007 Apr; 356(16):1609-19. PubMed ID: 17442904
[TBL] [Abstract][Full Text] [Related]
16. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
Holst LB
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
[TBL] [Abstract][Full Text] [Related]
17. A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery.
Nakamura RE; Vincent JL; Fukushima JT; de Almeida JP; Franco RA; Lee Park C; Osawa EA; Pinto Silva CM; Costa Auler JO; Landoni G; Barbosa Gomes Galas FR; Filho RK; Hajjar LA
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1314-20. PubMed ID: 26318355
[TBL] [Abstract][Full Text] [Related]
18. Liberal or restrictive transfusion in high-risk patients after hip surgery.
Carson JL; Terrin ML; Noveck H; Sanders DW; Chaitman BR; Rhoads GG; Nemo G; Dragert K; Beaupre L; Hildebrand K; Macaulay W; Lewis C; Cook DR; Dobbin G; Zakriya KJ; Apple FS; Horney RA; Magaziner J;
N Engl J Med; 2011 Dec; 365(26):2453-62. PubMed ID: 22168590
[TBL] [Abstract][Full Text] [Related]
19. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.
Tay J; Allan DS; Chatelain E; Coyle D; Elemary M; Fulford A; Petrcich W; Ramsay T; Walker I; Xenocostas A; Tinmouth A; Fergusson D
J Clin Oncol; 2020 May; 38(13):1463-1473. PubMed ID: 32083994
[TBL] [Abstract][Full Text] [Related]
20. Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial.
Stokes EA; Wordsworth S; Bargo D; Pike K; Rogers CA; Brierley RC; Angelini GD; Murphy GJ; Reeves BC;
BMJ Open; 2016 Aug; 6(8):e011311. PubMed ID: 27481621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
